ALAGILLE SYNDROME

Clinical trials for ALAGILLE SYNDROME explained in plain language.

Never miss a new study

Get alerted when new ALAGILLE SYNDROME trials appear

Sign up with your email to follow new studies for ALAGILLE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 3

New study tracks Real-World safety of odevixibat in rare liver disease

Disease control Not yet recruiting

This study will follow 30 people with Alagille syndrome who are taking odevixibat in their daily lives. The goal is to see how safe the drug is over the long term by tracking any side effects. It is not testing if the drug works, but rather monitoring its real-world safety.

Matched conditions: ALAGILLE SYNDROME

Sponsor: Ipsen • Aim: Disease control

Last updated Jun 27, 2026 12:33 UTC

ALAGILLE SYNDROME

Get alerted when new ALAGILLE SYNDROME trials appear

New study tracks Real-World safety of odevixibat in rare liver disease